Evidence report · Hormones and women's health
Verdict on whether hormone therapy around menopause does more good than harm for most women: Leaning for. Hormone therapy (HRT/MHT) is a reasonable and often helpful option for many women near menopause onset, and the blanket fear after the WHI study was an overcorrection. Transdermal estradiol with micronized progesterone is the preferred form. It is a decision to make with a menopause-trained clinician, not a self-prescribed protocol.
45 sources credited48 counted mentions18 episodes · 34 h48 checked quotesChecked against the tape 2026-06-24
Stance update (Aug 2026): An episode on hormones in psychiatry (#404) extends the WHI argument past breast cancer and into mood. A psychiatrist of 35 years said the reinterpretation of the Women's Health Initiative "changed prescribing practices so profoundly in general medicine" that he retrained in hormone therapy. He described women "whose adaptive capacities were higher, their ability to self-regulate and adjust to internal and external threats and changes was being eroded off of estradiol." The mechanism given is that estradiol modulates serotonin, dopamine, GABA, acetylcholine and glutamate signaling rather than boosting one of them, a different claim from the heart and cancer questions the WHI debate usually turns on. Source: youtube.com/watch?v=fs89fhQCfj4 at 54:14.
Stance update (Nov 2025): The U.S. FDA moved to remove the boxed ("black box") warning on menopausal hormone therapy: the warnings for cardiovascular disease, breast cancer and probable dementia. It is the regulatory catch-up to the WHI reframe. The endometrial-cancer warning for systemic estrogen-only therapy (in women with a uterus) stays. Label rewrites roll out over roughly six months, with new guidance noting benefits when therapy starts within ~10 years of menopause onset.
Each claim gets one verdict, worked out from every counted mention. One dot is one source: a researcher or a study. Tap a dot to see its receipt.
positive partly neutral negative Each researcher and each study counts once per claim, however often they come up.
Hormone therapy around menopause does more good than harm for most women.
12 sources: 4 positive, 8 partly.
Researchers say
3 positive, 5 partly
Sarah Zal, on The Diary Of A CEO, at 1:15:39
Positive Video · Opinion
Open the tape at 1:15:39 →“And by that I mean using hormone therapy and using lifestyle medicine as early as possible to manage that transition.”
Brian Kennedy, on The Drive, at 1:29:47
Positive Video · Opinion
Open the tape at 1:29:47 →“I just see the the value of of hormone replacement to far outweigh the risk in the majority of women.”
Rachel Rubin, on The Drive, at 01:47
Positive Video · Opinion
Open the tape at 01:47 →“So anyone should be offered hormone therapy because who wouldn't want to prevent osteoporosis”
Dr. Mary Claire Haver, on Huberman Lab, at 2:03:48
Partly Video · Opinion
Open the tape at 2:03:48 →“it will always protect her bones it will always protect her genital urinary system it will always protect her skin”
Joanne Manson, 2 mentions on this claim
Partly Video
on The Drive, at 49:51 · partly
“for a woman in early menopause at usual risk of breast cancer who would derive the benefits of symptom relief”
on The Drive, at 1:15:06 · partly
“in early menopause and generally good health the benefits are likely to outweigh the risk”
Dr. Annice Mukherjee, on Rangan Chatterjee's channel, at 46:34
Partly Video · Opinion
Open the tape at 46:34 →“the during the time she's got symptoms, which are for most women time limited, hormone therapy um has much more greater benefits than than harms.”
Dr. Lauren Colenso-Semple, on Huberman Lab, at 2:08:45
Partly Video · Opinion
Open the tape at 2:08:45 →“this is is really powerful and can be really effective for symptoms.”
Dr. Stacy Sims, on Rangan Chatterjee's channel, at 1:48:42
Partly Video · Opinion
Open the tape at 1:48:42 →“using menopause hormone therapy in conjunction to lifestyle is a win, but it's not for everyone.”
Studies show
1 positive, 3 partly
4 cited on tape, not yet checked against the paper
Danish Osteoporosis Prevention Study, cited on The Dr. Hyman Show, at 1:11:29
Positive Study
Open the tape at 1:11:29 →“the women who were on hormone therapy had a decreased risk of cardiovascular disease”
American Heart Association 2020, cited on Huberman Lab, at 1:13:47
Partly Study
Open the tape at 1:13:47 →“if you started hormone therapy between the ages of 50 to 59 you had a 50% decreased risk of cardiovascular disease”
Women's Health Initiative, cited on The Dr. Hyman Show, at 54:55
Partly Study
Open the tape at 54:55 →“the earlier you start in this process, the more long-term benefit you're going to get.”
Levy and Simon, Obstetrics and Gynecology 2024, cited on The Dr. Hyman Show, at 28:53
Partly Study
Open the tape at 28:53 →“we have a window of opportunity for protection for cardiovascular disease”
Sarah Zal, on The Diary Of A CEO, at 1:15:39 Video · positive · Opinion
“And by that I mean using hormone therapy and using lifestyle medicine as early as possible to manage that transition.”
Brian Kennedy, on The Drive, at 1:29:47 Video · positive · Opinion
“I just see the the value of of hormone replacement to far outweigh the risk in the majority of women.”
Rachel Rubin, on The Drive, at 01:47 Video · positive · Opinion
“So anyone should be offered hormone therapy because who wouldn't want to prevent osteoporosis”
Danish Osteoporosis Prevention Study, cited on The Dr. Hyman Show, at 1:11:29 Study · positive
“the women who were on hormone therapy had a decreased risk of cardiovascular disease”
Dr. Mary Claire Haver, on Huberman Lab, at 2:03:48 Video · partly · Opinion
“it will always protect her bones it will always protect her genital urinary system it will always protect her skin”
Joanne Manson Video · partly · 2 mentions
on The Drive, at 49:51 · partly · Opinion
“for a woman in early menopause at usual risk of breast cancer who would derive the benefits of symptom relief”
on The Drive, at 1:15:06 · partly · Opinion
“in early menopause and generally good health the benefits are likely to outweigh the risk”
Dr. Annice Mukherjee, on Rangan Chatterjee's channel, at 46:34 Video · partly · Opinion
“the during the time she's got symptoms, which are for most women time limited, hormone therapy um has much more greater benefits than than harms.”
Dr. Lauren Colenso-Semple, on Huberman Lab, at 2:08:45 Video · partly · Opinion
“this is is really powerful and can be really effective for symptoms.”
Dr. Stacy Sims, on Rangan Chatterjee's channel, at 1:48:42 Video · partly · Opinion
“using menopause hormone therapy in conjunction to lifestyle is a win, but it's not for everyone.”
American Heart Association 2020, cited on Huberman Lab, at 1:13:47 Study · partly
“if you started hormone therapy between the ages of 50 to 59 you had a 50% decreased risk of cardiovascular disease”
Women's Health Initiative, cited on The Dr. Hyman Show, at 54:55 Study · partly
“the earlier you start in this process, the more long-term benefit you're going to get.”
Levy and Simon, Obstetrics and Gynecology 2024, cited on The Dr. Hyman Show, at 28:53 Study · partly
“we have a window of opportunity for protection for cardiovascular disease”
2 more claims on dose, form and timing, each with its verdict and receipts, are in the full report.
5 risks to check before you start
Built from every credited researcher and cited study on each claim.
Hormone therapy around menopause does more good than harm for most women.
Researchers
Sarah Zal, on The Diary Of A CEO, at 1:15:39
Positive Video · Opinion
Open the tape at 1:15:39 →“And by that I mean using hormone therapy and using lifestyle medicine as early as possible to manage that transition.”
Brian Kennedy, on The Drive, at 1:29:47
Positive Video · Opinion
Open the tape at 1:29:47 →“I just see the the value of of hormone replacement to far outweigh the risk in the majority of women.”
Rachel Rubin, on The Drive, at 01:47
Positive Video · Opinion
Open the tape at 01:47 →“So anyone should be offered hormone therapy because who wouldn't want to prevent osteoporosis”
Studies
Danish Osteoporosis Prevention Study, cited on The Dr. Hyman Show, at 1:11:29
Positive Study
Open the tape at 1:11:29 →“the women who were on hormone therapy had a decreased risk of cardiovascular disease”
Researchers
Dr. Mary Claire Haver, on Huberman Lab, at 2:03:48
Partly Video · Opinion
Open the tape at 2:03:48 →“it will always protect her bones it will always protect her genital urinary system it will always protect her skin”
Joanne Manson, 2 mentions on this claim
Partly Video
on The Drive, at 49:51 · partly
“for a woman in early menopause at usual risk of breast cancer who would derive the benefits of symptom relief”
on The Drive, at 1:15:06 · partly
“in early menopause and generally good health the benefits are likely to outweigh the risk”
Dr. Annice Mukherjee, on Rangan Chatterjee's channel, at 46:34
Partly Video · Opinion
Open the tape at 46:34 →“the during the time she's got symptoms, which are for most women time limited, hormone therapy um has much more greater benefits than than harms.”
Dr. Lauren Colenso-Semple, on Huberman Lab, at 2:08:45
Partly Video · Opinion
Open the tape at 2:08:45 →“this is is really powerful and can be really effective for symptoms.”
Dr. Stacy Sims, on Rangan Chatterjee's channel, at 1:48:42
Partly Video · Opinion
Open the tape at 1:48:42 →“using menopause hormone therapy in conjunction to lifestyle is a win, but it's not for everyone.”
Studies
American Heart Association 2020, cited on Huberman Lab, at 1:13:47
Partly Study
Open the tape at 1:13:47 →“if you started hormone therapy between the ages of 50 to 59 you had a 50% decreased risk of cardiovascular disease”
Women's Health Initiative, cited on The Dr. Hyman Show, at 54:55
Partly Study
Open the tape at 54:55 →“the earlier you start in this process, the more long-term benefit you're going to get.”
Levy and Simon, Obstetrics and Gynecology 2024, cited on The Dr. Hyman Show, at 28:53
Partly Study
Open the tape at 28:53 →“we have a window of opportunity for protection for cardiovascular disease”
Precis is not affiliated with or endorsed by YouTube or by any researcher, show or publisher we quote. We take no sponsorship, ad or affiliate money, and every verdict is our own review of what was said. How we stay independent
This report on HRT & Menopause draws on 18 videos (34 hours analyzed) out of 3,800+ hours of recorded interviews with 380+ researchers and doctors, plus 87,700+ research studies. Every mention of a claim gets a stance, and the verdict is worked out from all of them, never written by hand.
The full report adds 8 key findings and the dose and protocol. It also has the verdict on every claim, a receipt for each mention, the risks to check, and what combines with it.
Get dosages, timing and the verdict on every claim with its receipts for HRT & Menopause.